Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

CNBC Markets

·

Original Report

↗ CNBC Markets

Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.